BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35538070)

  • 1. EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation.
    Zhang L; Qu J; Qi Y; Duan Y; Huang YW; Zhou Z; Li P; Yao J; Huang B; Zhang S; Yu D
    Nat Commun; 2022 May; 13(1):2543. PubMed ID: 35538070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
    Wendt MK; Schiemann WP
    Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IQGAP1 and NWASP promote human cancer cell dissemination and metastasis by regulating β1-integrin via FAK and MRTF/SRF.
    Cerutti C; Lucotti S; Menendez ST; Reymond N; Garg R; Romero IA; Muschel R; Ridley AJ
    Cell Rep; 2024 Apr; 43(4):113989. PubMed ID: 38536816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network.
    Yang J; Hou Y; Zhou M; Wen S; Zhou J; Xu L; Tang X; Du YE; Hu P; Liu M
    Int J Biochem Cell Biol; 2016 Feb; 71():62-71. PubMed ID: 26693891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway.
    Li XQ; Du X; Li DM; Kong PZ; Sun Y; Liu PF; Wang QS; Feng YM
    Cancer Res; 2015 Aug; 75(16):3302-13. PubMed ID: 26060017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.
    Gnani D; Romito I; Artuso S; Chierici M; De Stefanis C; Panera N; Crudele A; Ceccarelli S; Carcarino E; D'Oria V; Porru M; Giorda E; Ferrari K; Miele L; Villa E; Balsano C; Pasini D; Furlanello C; Locatelli F; Nobili V; Rota R; Leonetti C; Alisi A
    Cell Death Differ; 2017 May; 24(5):889-902. PubMed ID: 28338656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.
    Liu C; Qu L; Zhao C; Shou C
    J Exp Clin Cancer Res; 2018 Jun; 37(1):117. PubMed ID: 29903032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis.
    Hinz N; Baranowsky A; Horn M; Kriegs M; Sibbertsen F; Smit DJ; Clezardin P; Lange T; Schinke T; Jücker M
    Cells; 2021 Feb; 10(2):. PubMed ID: 33670586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA treatment targeting integrin α11 overexpressed via EZH2-driven axis inhibits drug-resistant breast cancer progression.
    Chaudhary P; Yadav K; Lee HJ; Kang KW; Mo J; Kim JA
    Breast Cancer Res; 2024 Apr; 26(1):72. PubMed ID: 38664825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
    Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophiopogonin D suppresses TGF-β1-mediated metastatic behavior of MDA-MB-231 breast carcinoma cells via regulating ITGB1/FAK/Src/AKT/β-catenin/MMP-9 signaling axis.
    Zhu X; Wang K; Chen Y
    Toxicol In Vitro; 2020 Dec; 69():104973. PubMed ID: 32818624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.
    Casar B; Rimann I; Kato H; Shattil SJ; Quigley JP; Deryugina EI
    Oncogene; 2014 Jan; 33(2):255-68. PubMed ID: 23208492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal intensity shock wave promotes the adhesion and migration of rat osteoblasts via integrin β1-mediated expression of phosphorylated focal adhesion kinase.
    Xu JK; Chen HJ; Li XD; Huang ZL; Xu H; Yang HL; Hu J
    J Biol Chem; 2012 Jul; 287(31):26200-12. PubMed ID: 22654119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis.
    Moore HM; Gonzalez ME; Toy KA; Cimino-Mathews A; Argani P; Kleer CG
    Breast Cancer Res Treat; 2013 Apr; 138(3):741-52. PubMed ID: 23539298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear SIPA1 activates integrin β1 promoter and promotes invasion of breast cancer cells.
    Zhang Y; Gong Y; Hu D; Zhu P; Wang N; Zhang Q; Wang M; Aldeewan A; Xia H; Qu X; Ring BZ; Minato N; Su L
    Oncogene; 2015 Mar; 34(11):1451-62. PubMed ID: 24704834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
    Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
    Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Site-Specific Glycosylation in the I-Like Domain of Integrin β1 in Small Extracellular Vesicle-Mediated Malignant Behavior and FAK Activation.
    Cao L; Wu Y; Wang X; Li X; Tan Z; Guan F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Sal-like 4 - integrin α6β1 network promotes cell migration for metastasis via activation of focal adhesion dynamics in basal-like breast cancer cells.
    Itou J; Tanaka S; Li W; Iida A; Sehara-Fujisawa A; Sato F; Toi M
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):76-88. PubMed ID: 27773610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance.
    Su JM; Gui L; Zhou YP; Zha XL
    World J Gastroenterol; 2002 Aug; 8(4):613-8. PubMed ID: 12174366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
    Yin H; Wang Y; Wu Y; Zhang X; Zhang X; Liu J; Wang T; Fan J; Sun J; Yang A; Zhang R
    Theranostics; 2020; 10(19):8494-8512. PubMed ID: 32754259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.